6533b86efe1ef96bd12cc81c

RESEARCH PRODUCT

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease

Patrizia SaliceMarco CattaliniFabio CardinalePaolo PalmaIsabella Tarissi De JacobisAndrea ZorziRolando CimazAngelo RavelliMaria Cristina MaggioGiovanni CorselloElisabetta CortisMaya El HachemAlessandro RiminiAlberto VillaniAurelio SecinaroDonato RiganteAndrea TaddioAlessandra MarchesiRosa Maria Dellepiane

subject

Pediatricsmedicine.medical_specialty2019-20 coronavirus outbreakAspirin; Children; Coronary artery abnormalities; Intravenous immunoglobulin; Kawasaki diseaseReview030204 cardiovascular system & hematologyMucocutaneous Lymph Node SyndromeDiagnosis Differential03 medical and health sciences0302 clinical medicine030225 pediatricshemic and lymphatic diseasesmedicineHumansChildCoronary artery abnormalitieChildrenIntravenous immunoglobulinAspirinAspirinKawasaki diseasebusiness.industryClinical courselcsh:RJ1-570Immunoglobulins Intravenouslcsh:PediatricsGeneral MedicineDelayed treatmentmedicine.diseasePrognosisSettore MED/38Disease phasesSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAEl NiñoItalyTreatment modalityDisease ProgressionAspirin Children Coronary artery abnormalities Intravenous immunoglobulin Kawasaki diseaseKawasaki diseasebusinessCoronary artery abnormalitiesmedicine.drug

description

AbstractAim of these revised recommendations for the general management of Kawasaki disease is to encourage its prompter recognition and warrant the most appropriate therapy, based on ascertained scientific data, raising awareness of the complications related to misdiagnosis or delayed treatment. A set of 20 synthetic operative statements is herein provided, including the definition of Kawasaki disease, its protean presentations, clinical course and seminal treatment modalities of all disease phases. The application of these recommendations should improve prognosis of Kawasaki disease and prevent the progression to permanent vascular abnormalities, thereby diminishing morbidity and mortality.

yearjournalcountryeditionlanguage
2021-01-25
10.1186/s13052-021-00962-4http://hdl.handle.net/11379/540196